FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

50841000172109: Belgian subset for AllergyIntolerance, causative agent, drug (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 15-Nov 2022. Module: Belgian module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
7891641000172111 Belgian subset for AllergyIntolerance, causative agent, drug en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) Belgian module (core metadata concept)
7891651000172113 Belgian subset for AllergyIntolerance, causative agent, drug (foundation metadata concept) en Fully specified name Active Only initial character case insensitive (core metadata concept) Belgian module (core metadata concept)
7891661000172110 sous-ensemble belge pour AllergyIntolerance, agent causal, médicaments fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Belgian module (core metadata concept)
7891671000172118 Belgische subset voor AllergyIntolerance, oorzakelijk agens, medicatie nl Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) Belgian module (core metadata concept)


6399 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Belgian subset for AllergyIntolerance, causative agent, drug Is a Simple type reference set (foundation metadata concept) true Inferred relationship Some

Members
Histamine H1 receptor antagonist
Histamine H2 receptor antagonist
Antihormone
Human epidermal growth factor receptor 2 inhibitor
Proton pump inhibitor
Hypothalamic inhibiting factor
Imidazole antifungal
Imidazoline receptor agonist
Integrase strand transfer inhibitor
Inter-alpha-trypsin inhibitor
Substance with interleukin 23 receptor antagonist mechanism of action (substance)
Substance with interleukin 5 receptor antagonist mechanism of action (substance)
Leukotriene receptor antagonist
Substance with macrolide structure and antibacterial mechanism of action (substance)
Mast cell stabiliser
Melatonin agonist
Mesenchymal epithelial transition inhibitor
Monoamine oxidase A inhibitor
Monoamine oxidase B inhibitor
Monoamine oxidase inhibitor
Muscarinic receptor agonist
Muscarinic receptor antagonist
Neuraminidase inhibitor
Neurokinin 1 receptor antagonist
Nicotinic receptor agonist
Substance with nicotinic receptor antagonist mechanism of action (substance)
Non-chaperonin molecular chaperone ATPase inhibitor
Substance with norepinephrine reuptake inhibitor and serotonin reuptake inhibitor mechanism of action (substance)
Noradrenaline reuptake inhibitor
Opioid receptor agonist
Substance with organophosphorus structure and acetylcholinesterase inhibitor mechanism of action (substance)
Substance with oxazolidinone structure and antibacterial mechanism of action (substance)
Oxidoreductase inhibitor
Substance with oxyquinoline structure (substance)
Substance with penicillin structure and antibacterial mechanism of action (substance)
Peroxisome proliferator-activated alpha receptor agonist
Peroxisome proliferator-activated receptor agonist
Substance with phosphoribosylglycinamide formyltransferase inhibitor mechanism of action (substance)
Plasmin inhibitor
Plasminogen activator inhibitor
Plasminogen activator
Platelet aggregation inhibitor
Potassium channel blocker
Progesterone receptor agonist
Substance with prolyl oligopeptidase inhibitor mechanism of action (substance)
PCSK9 inhibitor
Substance with prostaglandin-endoperoxide synthase inhibitor mechanism of action (substance)
Cyclooxygenase-1 inhibitor
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance)
Substance with prostaglandin-endoperoxide synthase isoform 3 inhibitor mechanism of action (substance)
Protease inhibitor
Proteasome inhibitor
Purine antagonist
Quinolone antibacterial
Substance with receptor activator of nuclear factor kappa-B ligand inhibitor mechanism of action (substance)
Renin inhibitor
Substance with renin-angiotensin system inhibitor mechanism of action (substance)
Reverse transcriptase inhibitor
Reversible anticholinesterase
Ribonucleoside-diphosphate reductase inhibitor
Substance with rifamycin structure
Scabicide
Selective adhesion molecule inhibitor
Serotonin 5-HT1 receptor agonist
Selective serotonin re-uptake inhibitor
Sodium glucose cotransporter subtype 2 inhibitor
Steroid 11-beta-monooxygenase inhibitor
Substance with sulfonamide structure and antibacterial mechanism of action (substance)
Sulfone antimycobacterial
Substance with tetracycline structure and antibacterial mechanism of action (substance)
Thrombopoietin receptor agonist
Triazole antifungal
Tumor necrosis factor alpha inhibitor
Tyrosine 3-monooxygenase inhibitor
Subtilisin
Succimer
Succinimide (substance)
Succinylated gelatin
Succinylcholine (substance)
Succinylcholine chloride (substance)
Succinylsulfathiazole
Sucralfate (substance)
Sufentanil
Sufentanil citrate
Sugammadex
Sugammadex sodium
Sulbactam
Sulbactam sodium (substance)
Sulbutiamine
Sulconazole (substance)
Sulconazole nitrate
Sulfabenzamide (substance)
Sulfabromomethazine
Sulfabromomethazine sodium
Sulfacarbamide (substance)
Sulfacetamide (substance)
Sulfacetamide sodium
Sulfachlorpyridazine
Sulfacytidine
Sulfacytine (substance)
Sulfadiazine

Start Previous Page 55 of 64 Next End


Reference Sets

Reference set descriptor

Back to Start